Objectives To estimate the prevalence of, and describe risk factors for, genital warts (GWs) in
the British population, following the introduction of the bivalent (human papillomavirus (HPV) …

Objectives To obtain health-related quality of life valuations (ie, utilities) for human
papillomavirus (HPV)-related cancer health states of vulval, vaginal, penile, anal and …

Background: Oropharyngeal cancer is an important, understudied cancer affecting
Aboriginal and Torres Strait Islander Australians. The human papillomavirus (HPV) is a …

Objective: Three vaccines are available to Taiwanese young girls for cervical cancer (CC)
prevention. Here we evaluate the cost-effectiveness of the two-dose (2D) AS04-adjuvanted …

Background Reproductive tract infections (RTI) and sexually transmitted infections (STI) are
often subclinical and remain undetected. The current study aimed to estimate the burden of …

Background Human papillomavirus (HPV) vaccines are ideally administered before HPV
exposure; therefore, catch-up programs for girls past adolescence have not been readily …

Background Many economic evaluations of human papillomavirus vaccination should
ideally consider multiple disease outcomes, including anogenital warts, respiratory …

Abstract Introduction In the United States, routine human papillomavirus (HPV) vaccination
is recommended for females and males at age 11 or 12 years; the series can be started at …

In the UK there are limited data about university students' risky sexual behaviour. A cross-
sectional web-survey was conducted to investigate factors associated with high-risk sex …

Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV‐related
disease and harms from vaccination - PMC Back to Top Skip to main content NIH NLM Logo …